Sitagliptin Metformin Lagap 50 mg/500 mg

Sitagliptin Metformin Lagap 50 mg/500 mg is a medicine authorised by Swissmedic under authorisation number 70161. The authorisation holder is Lagap SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 March 2026 and the authorisation is limited until 02 March 2031. ATC code A10BD07 places the medicine in the group Drugs used in diabetes.

  • Dispensing category B
  • Authorisation number 70161
  • ATC A10BD07
  • Synthetic medicines
Authorisation data
Authorisation number70161
NameSitagliptin Metformin Lagap 50 mg/500 mg
Full nameSitagliptin Metformin Lagap 50 mg/500 mg, Filmtabletten
Authorisation holderLagap SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA10BD07
First authorisation03 March 2026
Authorisation validity02 March 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Sitagliptin Metformin Lagap 50 mg/500 mg, FilmtablettenB03 March 2026
2Sitagliptin Metformin Lagap 50 mg/850 mg, FilmtablettenB03 March 2026
3Sitagliptin Metformin Lagap 50 mg/1000 mg, FilmtablettenB03 March 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
156Tablette(n)A10BD0707.06.2.B
256Tablette(n)A10BD0707.06.2.B
356Tablette(n)A10BD0707.06.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Sitagliptin Metformin Lagap 50 mg/500 mg authorised in Switzerland?

Yes. Sitagliptin Metformin Lagap 50 mg/500 mg is authorised by Swissmedic under authorisation number 70161, data as of 01 September 2026. The authorisation is limited until 02 March 2031.

Which dispensing category does Sitagliptin Metformin Lagap 50 mg/500 mg have?

Sitagliptin Metformin Lagap 50 mg/500 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Sitagliptin Metformin Lagap 50 mg/500 mg?

The authorisation holder is Lagap SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com